Bitnomial launches Injective futures in US, with eyes on ETF eligibility

CoinTelegraph Published Updated Cryptocurrency
Sign in to save

Why it matters

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.

Article tone

Neutral How the article is written, as reported by the source.

Expected market reaction

Neutral Confidence 94% How confidence is read Horizon: Short term Impact: Low

Evidence trail

Evidence
Source CoinTelegraph
Claim Bitnomial launches Injective futures in US, with eyes on ETF eligibility
AI inference Neutral · 94%
Generated 2026-04-15 21:13

AI provenance

Analysed by FinBERT Methodology v1.0 Generated
Technical identifiers
Provider tag
huggingface-ProsusAI/finbert
Analysis version
huggingface-ProsusAI/finbert
Article id
71596

Original source

The contracts mark Injective’s first entry into US-regulated derivatives markets and could help support a spot ETF following a filing from Canary Capital.

Read the full article on CoinTelegraph

Original article published by CoinTelegraph on April 16, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage